Proparacaine

Table of contents

  • Brand Names
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Drug Interactions
  • Dosage

Brand Names

Europe

Belgium: Alcaine; Bulgaria: Alcaine; Cyprus: Alcaine; Estonia: Alcaine; Germany: Proparakain; Greece: Alcaine; Ireland: Minims Proxymetacaine; Italy: Visuanestetico; Lithuania: Alcaine; Luxembourg: Keracaine; Poland: Alcaine; Slovenia: Alcaine; UK: Minims Proxymetacaine.

North America

Canada: Ak Taine, Alcaine, Diocaine, Ophthetic; USA: Alcaine, Ophthaine, Ophthetic, Proparacaine.

Latin America

Argentina: Anestalcón, Poencaína; Brazil: Anestalcon, Visonest; Mexico: Alcaíne.

Drug combinations

Chemistry

Proparacaine Hydrochloride: C~16~H~26~N~2~O~3~ HCl. Mw: 330.85. (1) Benzoic acid, 3-amino-4-propoxy-, 2-(diethylamino)ethyl ester, monohydrochloride; (2) 2-(Diethylamino)ethyl 3-amino-4-propoxybenzoate monohydrochloride. CAS-5875-06-9; CAS-499-67-2 (proparacaine).

Pharmacologic Category

EENT Preparations; Local Anesthetics. Ophthalmic Local Anesthetic. (ATC-Code: N01BA04).

Mechanism of action

Prevents initiation and transmission of impulse at nerve cell membrane by decreasing ion permeability through stabilizing.

Therapeutic use

Anesthesia for tonometry, gonioscopy. Suture removal from cornea. Removal of corneal foreign body. Cataract extraction, glaucoma surgery. Short operative procedure involving cornea and conjunctiva.

Pregnancy and lactiation implications

Unlabeled use

Contraindications

Hypersensitivity to proparacaine or any component of the formulation.

Warnings and precautions

For topical ophthalmic use only. Prolonged use not recommended.

Information

Legal

Legal Notice
Privacy Policy
Cookie Policy

Contact

Phone: +34-981-780505
Email: genomicmedicine@wagem.org
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart